Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Finotti A, Gambari R (2014) Recent trends for novel options in experimental biological therapy of β-thalassemia. Expert Opin Biol Therapy 14:1443–1454
2. El-Beshlawy A, Kaddah N, Moustafa A, Mouktar G, Youssry I (2007) Screening for beta-thalassaemia carriers in Egypt: significance of the osmotic fragility test. East Mediterr Health J 13:780–786
3. Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W et al (2007) Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload. Am J Hematol 82:255–265
4. Singer ST (2009) Variable clinical phenotypes of alpha-thalassemia syndromes. Sci World J 9:615–625
5. Deborah Chirnomas S, Geukes-Foppen M, Barry K, Braunstein J, Kalish LA, Neufeld EJ et al (2008) Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias. Am J Hematol 83:781–783
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献